Advertisement

Pharmaceutical Chemistry Journal

, Volume 29, Issue 11, pp 773–776 | Cite as

Synthesis and study of structure-antiallergic activity relationship in a series of 4-R-3-cinnamoylcoumarin derivatives

  • E. T. Oganesyan
  • Yu. S. Gridnev
  • A. S. Saraf
  • A. V. Pogrebnyak
Search for New Drugs
  • 30 Downloads

Keywords

Organic Chemistry Activity Relationship 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    N. B. Piller,Arzneimittel. Forsch. 27(6), 1135–1138 (1977).Google Scholar
  2. 2.
    M. Borges and M. Feruauda,Rev. Port. Pharm.,37(4), 47–57 (1987).Google Scholar
  3. 3.
    W. Konig, W. Sehoufeld, M. Raulf. et al.,Eicosauoids,3, 1–22 (1990).Google Scholar
  4. 4.
    M. S. Koh, and D. A. Willooughby,Agents & Actions,9(3), 284–289 (1979).Google Scholar
  5. 5.
    C. M. Winslow, and R. F. Austen,Fed. Proc.,41, 22–29 (1982).PubMedGoogle Scholar
  6. 6.
    D. R. Buckle, B. C. Cantello, H. Smith, et al.,J. Med. Chem.,18(4), 391–394 (1975).CrossRefPubMedGoogle Scholar
  7. 7.
    A. Roesch and E. Roesch,Brit. J. Pharmacol.,57(3), 438 (1976).Google Scholar
  8. 8.
    Patent 1555753 Great Britain. Appl. 11.02.77. Published 14.11.79.7; Patent 640848 Switzerland. Appl. 01.07.78. Publ. 31.01.84.Google Scholar
  9. 9.
    A. S. Saraf and A. V. Simonyan,Khim.-Farm. Zh.,26(7–8), 45–48 (1992).Google Scholar
  10. 10.
    D. R. Buckle, D. I. Outred, H. Smith, et al.,J. Med. Chem.,27, 1452–1457 (1984).PubMedGoogle Scholar
  11. 11.
    É. T. Oganesyan, A. S. Saraf, and A. V. Ivchenko,Khim.-Farm. Zh.,27(1), 41–43 (1993).Google Scholar
  12. 12.
    E. T. Oganesyan, A. V. Ivchenko, I. P. Kodonidi, et al.,Khim.-Farm. Zh.,27(3), 10–13 (1993).Google Scholar
  13. 13.
    I. S. Gushchin, N. L. Bogush, V. A. Aleshkin, et al.,Immunologiya, No. 1, 61–63 (1986).Google Scholar
  14. 14.
    E. T. Oganesyan, A. S. Saraf, A. V. Simonyan, et al.,Khim-Farm. Zh.,25(8), 18–20 (1991).Google Scholar
  15. 15.
    E. T. Oganesyan, A. V. Pogrebnyak, and Yu. S. Gridnev,Khim.-Farm. Zh.,28(11), 36–39 (1994).Google Scholar
  16. 16.
    M. Rajzmann and P. Francois,QCPE No. 383a, Indiana University, Bloomington, Indiana (1987).Google Scholar
  17. 17.
    K. B. Wiberg,Tetrahedron,20, 1083 (1968).Google Scholar
  18. 18.
    H. Mager and A. Barth,Pharmazie,34, 557–559 (1979).PubMedGoogle Scholar
  19. 19.
    E. M. Vaz, N. M. Vaz, and B. B. Levine,Immunology,2, 11–15 (1971).Google Scholar
  20. 20.
    A. W. Lykke and R. Cummings,Brit. J. Exp. Path.,50, 309–318 (1969).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • E. T. Oganesyan
    • 1
  • Yu. S. Gridnev
    • 1
  • A. S. Saraf
    • 1
  • A. V. Pogrebnyak
    • 1
  1. 1.Pharmaceutical InstitutePyatigorskRussia

Personalised recommendations